Table of Contents

Preface; Mitogen-Activated Protein Kinase (MAPK) Inhibitors for The Treatment of Advanced Hepatocellular Carcinoma; Protein Farnesyltransferase Inhibitors as Novel Anticancer Chemotherapeutics; Peptidylarginine Deiminase (PAD) Inhibitors; Interfering with Enzymatic Steps of Micrornas Pathway Using Small Molecules; In Silico Studies for the Discovery of Leads to Inhibit Cyclin-Dependent Kinase 2 (CDK2); Design & Development of Tyrosine Kinase Inhibitors as Anticancer Drugs; In Silico Design of Carbonic Anhydrase Inhibitors as Antitumor Drugs; Studies on Inhibitors of Dengue Virus Protease; Design & Development of Inhibitors of Picornavirus Proteases; Neuraminidase Inhibitors: From Research Tools to Drug Candidates; Recent Developments in HIV-1 Integrase Inhibitors; Studies on Dual Inhibitors of HIV Reverse Transcriptase & Integrase; Index.